4Vote!
Business Wire (Free subscription) | 10/29/2009
DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) ("Elan") today announced the expiration and final results of the tender offer for the 7¾% Senior Fixed Rate Notes due 2011 (CUSIP No. 284138AC8) (the “Notes”) issued by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. (the “Co-Issuers”). The tender offer expired...
3Vote!
Medical News Today (Free subscription) | 10/28/2009
Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) announced data showing that treatment with TYSABRI® (natalizumab) significantly reduced the rate of hospitalization compared with placebo in patients with moderate - to - severe Crohn's disease during both induction and maintenance treatment.
4Vote!
Business Wire (Free subscription) | 10/27/2009
DUBLIN & SAN DIEGO--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDAQ: BIIB) today announced data showing that treatment with TYSABRI® (natalizumab) significantly reduced the rate of hospitalization compared with placebo in patients with moderate–to–severe Crohn’s disease during both induction and maintenance treatment. These results were obtained...
4Vote!
Business Wire (Free subscription) | 10/21/2009
DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc today reported its third quarter 2009 financial results. Elan CEO Kelly Martin said, “The third quarter of 2009 proved to be a time of significant transformation for Elan. Completion of the Johnson & Johnson transaction and the subsequent refinancing of our balance sheet provide strategic flexibility and financial stability for the company.”...
3Vote!
Money Prophet (Free subscription) | 10/21/2009
DUBLIN----Elan Corporation, plc today reported its third quarter 2009 financial results.
4Vote!
The Earth Times Online Newspaper (Free subscription) | 10/19/2009
DUBLIN, Ireland & SOUTH SAN FRANCISCO, Calif. - Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDQ: BIIB) today announced multiple presentations at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place October 23-28 in San Diego.
4Vote!
Business Wire (Free subscription) | 10/19/2009
DUBLIN, Ireland & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) and Biogen Idec (NASDQ: BIIB) today announced multiple presentations at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place October 23-28 in San Diego. The posters and presentations during ACG will highlight TYSABRI® (natalizumab) data in treating Crohn’s...
4Vote!
Business Wire (Free subscription) | 10/14/2009
DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc (NYSE:ELN) ("Elan") today announced the results as of the early tender date of the tender offer for the 7¾% Senior Fixed Rate Notes due 2011 (CUSIP No. 284138AC8) (the “Notes”) issued by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. (the “Co-Issuers”). As of 11:59 p.m.,...
4Vote!
Business Wire (Free subscription) | 10/07/2009
DUBLIN, Ireland--(BUSINESS WIRE)--Elan Corporation, plc (NYSE: ELN) announced today that it will host a conference call on Wednesday, October 21, 2009 at 8:30 a.m. Eastern Time (ET), 1:30 p.m. British Summer Time (BST) with the investment community to discuss Elan’s third quarter 2009 financial results, which will be released before the European and U.S. financial markets open. Live audio of...
6Vote!
Business Wire (Free subscription) | 09/30/2009
DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc ("Elan") today announced the pricing of the offering of US$625 million aggregate principal amount of senior notes due 2016 (“New Notes”) by its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp. The New Notes will carry a coupon of 8.75% per annum, payable semi-annually in arrears beginning April...
3Vote!
Reuters UK (Free subscription) | 09/29/2009
NEW YORK (Reuters) - Elan Corp Plc said on Tuesday it received a U.S. Securities and Exchange Commission subpoena over its disclosure of two cases of an often fatal brain disorder tied to use of its Tysabri multiple sclerosis drug.
3Vote!
ireland.com (Free subscription) | 09/29/2009
Elan Corp has today announced a cash tender offer for the existing senior fixed-rate notes of $850 million that is due in 2011.
4Vote!
Business Wire (Free subscription) | 09/29/2009
DUBLIN--(BUSINESS WIRE)--Elan Corporation, plc ("Elan") today announced that its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., intend to offer, subject to market conditions, US$600 million in aggregate principal amount of senior fixed rate notes due 2016 (the “New Notes”). The New Notes will be offered to qualified institutional buyers...
4Vote!
Business Wire (Free subscription) | 09/29/2009
DUBLIN, Ireland--(BUSINESS WIRE)--Elan Corporation, plc ("Elan") today announced that its wholly-owned subsidiaries, Elan Finance public limited company and Elan Finance Corp., are commencing a cash tender offer (the “Tender Offer”) for the outstanding US$850 million in aggregate principal amount of their 7 3/4% senior fixed rate notes due 2011 (the “2011 Fixed Rate Notes”)....
Videos